InvestorsHub Logo
Followers 6
Posts 601
Boards Moderated 0
Alias Born 09/05/2013

Re: coldasice post# 10906

Wednesday, 11/08/2017 1:00:30 PM

Wednesday, November 08, 2017 1:00:30 PM

Post# of 12138
Watching the price action, I'll go with a hypothesis the market just got ahead of itself. We have the first 2 immuno therapies approved EVER? I'm just really disappointed in myself for not recognizing the over exuberant buying and take some profits at $10.

Did any of us expect to hit $10 so quickly? Especially how we've watched revenues climb at a snails pace? Yeah 50% here %50 there...but reporting in dollars would make for poor headlines. We are still in an infant growth stage(going on for years now), and the latest quarterly report/conference call gave the market more ammunition to work the price down.

Yes, the future is still bright, but the tunnel got a bit longer for new investors when they hear the grand prize commercializations will take 3 YEARS to fully contribute to the bottom line. Granted there are other revenue streams that will take hold, but when is anyones guess.

So I guess my take is the market has repriced the stock to where it probably deserves. We only have what 12 to 15 million annual revenues? Market cap 10 to 15 times that? I'd say we are still valued very positively by the market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News